The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
PINK1-linked parkinsonism is associated with Lewy body pathology
Abstract
Phosphatase and tensin homolog-induced putative kinase 1 gene mutations have been associated with autosomal recessive early-onset Parkinson's disease. To date, no neuropathological reports have been published from patients with Parkinson's disease with both phosphatase and tensin homolog-induced putative kinase 1 gene copies mutated. We analysed the coding region of phosphatase and tensin homolog-induced putative kinase 1 gene in a large Spanish family with six members with parkinsonism. The phenotype was characterized by an early-onset (mean: 31.6, standard deviation: 9.6 years, range: 14-45 years), slowly progressive levodopa-responsive parkinsonism, initial gait impairment and psychiatric symptoms. We identified two segregating pathogenic phosphatase and tensin homolog-induced putative kinase 1 mutations that were either in homozygous or heterozygous compound state in all affected family members. We found an exon 7 deletion (g.16089_16383del293; c.1252_1488del) and a novel+1U1-dependent 5' splice-site mutation in exon 7 (g.16378G>A; c.1488+1G>A). Leukocyte-derived messenger RNA analysis showed that both mutations caused exon 7 skipping and c.1488+1G>A also lead to an in-frame transcript with a 33 base-pair deletion (p.L485_R497del) resulting from activation of a 5' cryptic exon 7 splice site. Single photon emission computed tomography quantification of striatal dopamine transporter binding (123I-Ioflupane) revealed a posterior-anterior gradient similar to that of idiopathic Parkinson's disease, but there was no correlation between striatal reduced uptake and disease duration. Post-mortem neuropathological examination of an early-onset Parkinson's disease carrier of two heterozygous compound phosphatase and tensin homolog-induced putative kinase 1 mutations showed neuronal loss in the substantia nigra pars compacta, Lewy bodies and aberrant neurites in the reticular nuclei of the brainstem, substantia nigra pars compacta and Meynert nucleus, but the locus ceruleus and the amygdala were spared. This is the first neuropathological report of the brain from an early-onset phosphatase and tensin homolog-induced putative kinase 1-linked parkinsonism showing that mutated phosphatase and tensin homolog-induced putative kinase 1 protein induces Lewy body pathology. Unbalanced preservation of the locus ceruleus may well play a role in the slow evolution of motor symptoms and, probably, in the psychiatric symptoms often encountered in Parkinson's disease associated with phosphatase and tensin homolog-induced putative kinase 1 mutation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Aston-Jones, G., & Cohen, J. D. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135709 · Cited by 4,472
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibanez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,778
Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion
Dunnen, J. T. D., & Antonarakis, S. E. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200001)15:1<7::aid-humu4>3.0.co;2-n · Cited by 1,756
PINK1-dependent recruitment of Parkin to mitochondria in mitophagy
Vives-Bauza, C., Zhou, C., Huang, Y., Cui, M., de Vries, R. L. A., Kim, J., May, J., Tocilescu, M. A., Liu, W., Ko, H. S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911187107 · Cited by 1,616
Association between Early-Onset Parkinson's Disease and Mutations in the Parkin Gene
Lücking, C. B., Dürr, A., Bonifati, V., Vaughan, J., De Michele, G., Gasser, T., Harhangi, B. S., Meco, G., Denèfle, P., Wood, N. W., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005253422103 · Cited by 1,433
Dagda, R. K., Cherra, S. J., Kulich, S. M., Tandon, A., Park, D., & Chu, C. T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808515200 · Cited by 954
Braak, H., Del Tredici, K., Bratzke, H., Hamm-Clement, J., Sandmann-Keil, D., & Rüb, U. (2002) · Journal of Neurology · doi:10.1007/s00415-002-1301-4 · Cited by 708
Sherer, T. B., Betarbet, R., Stout, A. K., Lund, S., Baptista, M., Panov, A. V., Cookson, M. R., & Greenamyre, J. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07006.2002 · Cited by 581
de Rijk, M. C., Launer, L. J., Berger, K., Breteler, M. M. B., Dartigues, J. F., Baldereschi, M., Fratiglioni, L., Lobo, A., Martinez-Lage, J., Trenkwalder, C., et al. (2000) · PubMed · Cited by 528
Prevalence of Parkinson's disease in Europe : A collaborative study of population-based cohorts
de Rijk, M. C., Launer, L. J., Berger, K., Breteler, M. M. B., Dartigues, J. F., Baldereschi, M., Fratiglioni, L., Lobo, A., Martínez‐Lage, J. M., Trenkwalder, C., et al. (2000) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 514
PINK1 mutations are associated with sporadic early‐onset parkinsonism
Valente, E. M., Salvi, S., Ialongo, T., Marongiu, R., Elia, A. E., Caputo, V., Romito, L., Albanese, A., Dallapiccola, B., & Bentivoglio, A. R. (2004) · Annals of Neurology · doi:10.1002/ana.20256 · Cited by 505
Valente, E. M., Bentivoglio, A. R., Dixon, P. H., Ferraris, A., Ialongo, T., Frontali, M., Albanese, A., & Wood, N. W. (2001) · The American Journal of Human Genetics · doi:10.1086/319522 · Cited by 493
Lewy bodies and parkinsonism in families with parkin mutations
Farrer, M., Chan, P., Chen, R., Tan, L., Lincoln, S., Hernandez, D., Forno, L., Gwinn‐Hardy, K., Petrucelli, L., Hussey, J., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1132 · Cited by 485
Burn, D. J. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.081711 · Cited by 436
Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation
Xiong, H., Wang, D., Chen, L., Choo, Y. S., Ma, H., Tang, C., Xia, K., Jiang, W., Ronai, Z., Zhuang, X., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37617 · Cited by 392
The role of pathogenic DJ‐1 mutations in Parkinson's disease
Abou‐Sleiman, P. M., Healy, D. G., Quinn, N., Lees, A. J., & Wood, N. W. (2003) · Annals of Neurology · doi:10.1002/ana.10675 · Cited by 383
Gispert, S., Ricciardi, F., Kurz, A., Azizov, M., Hoepken, H.-H., Becker, D., Voos, W., Leuner, K., Müller, W. E., Kudin, A. P., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005777 · Cited by 381
Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q
Mori, H., Kondo, T., Yokochi, M., Matsumine, H., Nakagawa-Hattori, Y., Miyake, T., Suda, K., & Mizuno, Y. (1998) · Neurology · doi:10.1212/wnl.51.3.890 · Cited by 370
PINK1 protein in normal human brain and Parkinson's disease
Gandhi, S. (2006) · Brain · doi:10.1093/brain/awl114 · Cited by 342
How much phenotypic variation can be attributed to parkin genotype?
Lohmann, E., Periquet, M., Bonifati, V., Wood, N. W., De Michele, G., Bonnet, A., Fraix, V., Broussolle, E., Horstink, M. W. I. M., Vidailhet, M., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10613 · Cited by 301
Parkin mutations are frequent in patients with isolated early‐onset parkinsonism
Periquet, M., Latouche, M., Lohmann, E., Rawal, N., De Michele, G., Ricard, S., Teive, H., Fraix, V., Vidailhet, M., Nicholl, D., et al. (2003) · Brain · doi:10.1093/brain/awg136 · Cited by 292
Stabilization and ribosome association of unspliced pre-mRNAs in a yeast upf1- mutant.
He, F., Peltz, S. W., Donahue, J. L., Rosbash, M., & Jacobson, A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.7034 · Cited by 269
Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations
van de Warrenburg, B. P. C., Lammens, M., Lücking, C. B., Denèfle, P., Wesseling, P., Booij, J., Praamstra, P., Quinn, N., Brice, A., & Horstink, M. W. I. M. (2001) · Neurology · doi:10.1212/wnl.56.4.555 · Cited by 255
Applying nonsense-mediated mRNA decay research to the clinic: progress and challenges
Kuzmiak, H. A., & Maquat, L. E. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.05.005 · Cited by 253
Lewy body Parkinson's disease in a large pedigree with 77Parkin mutation carriers
Pramstaller, P. P., Schlossmacher, M. G., Jacques, T. S., Scaravilli, F., Eskelson, C., Pepivani, I., Hedrich, K., Adel, S., Gonzales-McNeal, M., Hilker, R., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20587 · Cited by 247
Hayashi, S., Wakabayashi, K., Ishikawa, A., Nagai, H., Saito, M., Maruyama, M., Takahashi, T., Ozawa, T., Tsuji, S., & Takahashi, H. (2000) · Movement Disorders · doi:10.1002/1531-8257(200009)15:5<884::aid-mds1019>3.0.co;2-8 · Cited by 212
(2000) · Neurology · doi:10.1212/wnl.54.5.21a · Cited by 209
Khan, N. L., Valente, E. M., Bentivoglio, A. R., Wood, N. W., Albanese, A., Brooks, D. J., & Piccini, P. (2002) · Annals of Neurology · doi:10.1002/ana.10417 · Cited by 199
Formation and development of Lewy pathology: a critical update
Jellinger, K. A. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5243-y · Cited by 190
Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa
Ibáñez, P., Lesage, S., Lohmann, E., Thobois, S., Michele, G. D., Borg, M., Agid, Y., Dürr, A., & Brice, A. (2006) · Brain · doi:10.1093/brain/awl005 · Cited by 182
Marongiu, R., Spencer, B. J., Crews, L. A., Adame, A., Patrick, C., Trejo, M., Dallapiccola, B., Valente, E. M., & Masliah, E. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05932.x · Cited by 173
Liu, W., Vives-Bauzá, C., Acín‐Pérez, R., Yamamoto, A., Tan, Y.-C., Li, Y., Magrané, J., Stavarache, M. A., Shaffer, S., Chang, S. H., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004597 · Cited by 154
Tissingh, G., Booij, J., Bergmans, P., Winogrodzka, A., Janssen, A. G. M., van Royen, E. A., Stoof, J. C., & Wolters, E. C. (1998) · PubMed · Cited by 140
Clinicogenetic study of PINK1 mutations in autosomal recessive early-onset parkinsonism
Li, Y., Tomiyama, H., Sato, K., Hatano, Y., Yoshino, H., Atsumi, M., Kitaguchi, M., Sasaki, S., Kawaguchi, S., Miyajima, H., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000164009.36740.4e · Cited by 138
Protein Misfolding and Aggregation in Parkinson's Disease
Tan, J. M. M., Wong, E. S. P., & Lim, K. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2490 · Cited by 135
Parkin and Parkinsonʼs disease
Mizuno, Y., Hattori, N., Mori, H., Suzuki, T., & Tanaka, K. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200108000-00008 · Cited by 126
Homozygous PINK1 C‐terminus mutation causing early‐onset parkinsonism
Rohé, C. F., Montagna, P., Breedveld, G. J., Cortelli, P., Oostra, B. A., & Bonifati, V. (2004) · Annals of Neurology · doi:10.1002/ana.20247 · Cited by 126
Mechanism for cryptic splice site activation during pre-mRNA splicing.
Nelson, K. K., & Green, M. R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.16.6253 · Cited by 98
Bing, G., Zhang, Y., Watanabe, Y., McEwen, B. S., & Stone, E. A. (1994) · Brain Research · doi:10.1016/0006-8993(94)90534-7 · Cited by 96
Kochhar, A., Orten, D. J., Sorensen, J. L., Fischer, S. M., Cremers, C. W. R. J., Kimberling, W. J., & Smith, R. J. (2008) · Human Mutation · doi:10.1002/humu.20714 · Cited by 95
[Psychotic symptoms in Parkinson's disease].
Fénelon, G. (2006) · PubMed · Cited by 92
Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice
Marien, M. R., Briley, M., & Colpaert, F. C. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90489-5 · Cited by 92
The PINK1 phenotype can be indistinguishable from idiopathic Parkinson disease
Albanese, A., Valente, E. M., Romito, L. M., Bellacchio, E., Elia, A. E., & Dallapiccola, B. (2005) · Neurology · doi:10.1212/01.wnl.0000163999.72864.fd · Cited by 88
Pink1 suppresses α-synuclein-induced phenotypes in a Drosophila model of Parkinson’s disease
Todd, A. M., & Staveley, B. E. (2008) · Genome · doi:10.1139/g08-085 · Cited by 84
Intrinsic and extrinsic psychosis in Parkinson's disease
Wolters, E. C. (2001) · Journal of Neurology · doi:10.1007/pl00007822 · Cited by 84
Santpere, G., & Ferrer, I. (2009) · Acta Neuropathologica · doi:10.1007/s00401-008-0478-8 · Cited by 83
Self-citationPINK1heterozygous rare variants: prevalence, significance and phenotypic spectrum
Marongiu, R., Ferraris, A., Ialongo, T., Michiorri, S., Soleti, F., Ferrari, F., Elia, A. E., Ghezzi, D., Albanese, A., Altavista, M. C., et al. (2008) · Human Mutation · doi:10.1002/humu.20719 · Cited by 78
Weiss, J. M., Boss-Williams, K. A., Moore, J. P., Demetrikopoulos, M. K., Ritchie, J., & West, C. H. K. (2005) · Neuropeptides · doi:10.1016/j.npep.2004.12.028 · Cited by 77
Whole gene deletion and splicing mutations expand thePINK1 genotypic spectrum
Marongiu, R., Brancati, F., Antonini, A., Ialongo, T., Ceccarini, C., Scarciolla, O., Capalbo, A., Benti, R., Pezzoli, G., Dallapiccola, B., et al. (2006) · Human Mutation · doi:10.1002/humu.9472 · Cited by 76
The human locus coeruleus in neurology and psychiatry
van Dongen, P. A. M. (1981) · Progress in Neurobiology · doi:10.1016/0301-0082(81)90005-8 · Cited by 73
Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine depletion in mice
Fornai, F., Bassi, L., Torracca, M. T., Scalori, V., & Corsini, G. U. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00313-a · Cited by 71
Camargos, S., de Oliveira, L. D., Momeni, P., Lees, A. J., Hardy, J., Singleton, A., & Cardoso, F. (2009) · Movement Disorders · doi:10.1002/mds.22365 · Cited by 70
Co-occurrence of affective and schizophrenia spectrum disorders with PINK1 mutations
Steinlechner, S., Stahlberg, J., Volkel, B., Djarmati, A., Hagenah, J., Hiller, A., Hedrich, K., König, I. R., Klein, C., & Lencer, R. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.105676 · Cited by 65
PINK1 mutations and parkinsonism
Ishihara-Paul, L., Hulihan, M., Kachergus, J. M., Upmanyu, R., Warren, L. L., Amouri, R., Elango, R., Prinjha, R. K., Soto, A., Kéfi, M., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000323812.40708.1f · Cited by 63
Baumann, B., Dános, P., Krell, D., Diekmann, S., Wurthmann, C., Bielau, H., Bernstein, H., & Bogerts, B. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00168-2 · Cited by 53
Leutenegger, A., Salih, M. A. M., Ibáñez, P., Mukhtar, M. M., Lesage, S., Arabi, A., Lohmann, E., Dürr, A., Ahmed, A. E., & Brice, A. (2006) · Archives of Neurology · doi:10.1001/archneur.63.9.1257 · Cited by 43
Dopaminergic function in a family with the PARK6 form of autosomal recessive Parkinson’s syndrome
Kessler, K. R., Hamscho, N., Morales, B., Menzel, C., Barrero, F. J., Vives, F., Gispert, S., & Auburger, G. W. J. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0281-9 · Cited by 40
Mitochondrial autophagy as a compensatory response to PINK1 deficiency
Cherra, S. J., Dagda, R. K., Tandon, A., & Chu, C. T. (2009) · Autophagy · doi:10.4161/auto.5.8.10050 · Cited by 39
Cazeneuve, C., Sân, C., Ibrahim, S. A., Mukhtar, M. M., Kheir, M. M., Leguern, É., Brice, A., & Salih, M. A. M. (2009) · Neurogenetics · doi:10.1007/s10048-009-0174-4 · Cited by 33
Clinicogenetic study of PINK1 mutations in autosomal recessive early-onset parkinsonism
李, 元. (2008) · Cited by 33
Cited by
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
Pickrell, A. M., & Youle, R. J. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.007 · Cited by 2,310
“However, it is controversial whether or not Parkin and PINK1 patients have a different neuropathological presentation of Lewy body formation as compared to sporadic cases (Houlden and Singleton, 2012; Kitada et al., 1998; Pramstaller et al., 2005; Samaranch et al., 2010).”
BackgroundInflammation and immune dysfunction in Parkinson disease
Tansey, M. G., Wallings, R. L., Houser, M. C., Herrick, M. K., Keating, C. E., & Joers, V. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00684-6 · Cited by 1,382
Genetics of Parkinson's Disease
Klein, C., & Westenberger, A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a008888 · Cited by 1,358
Goedert, M., Spillantini, M. G., Del Tredici, K., & Braak, H. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.242 · Cited by 1,190
Scotti, M. M., & Swanson, M. S. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2015.3 · Cited by 1,163
Metadata
- Authors
- Samaranch, L., Lorenzo-Betancor, O., Arbelo, J. M., Ferrer, I., Lorenzo, E., Irigoyen, J., Pastor, M. A., Marrero, C., Isla, C., Herrera-Henriquez, J., & Pastor, P.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-03-30
- Volume
- 133
- Issue
- 4
- Pages
- 1128-1142
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W1980449640
- Cited by
- 258
- References
- 63
- FWCI
- 11.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.